I read with great interest about a study that assessed the characteristics of pivotal trials with innovative and modified new anticancer drugs approved in China[1].In this letter,I reflect on the study designs of thes...I read with great interest about a study that assessed the characteristics of pivotal trials with innovative and modified new anticancer drugs approved in China[1].In this letter,I reflect on the study designs of these trials,given the context of oncology trial development in China and internationally.展开更多
文摘I read with great interest about a study that assessed the characteristics of pivotal trials with innovative and modified new anticancer drugs approved in China[1].In this letter,I reflect on the study designs of these trials,given the context of oncology trial development in China and internationally.
